Literature DB >> 32022135

Demyelination in experimental intraventricular neurocysticercosis.

Vania Beatriz Lopes Moura1, Analia Cirqueira Milhomem2, Sarah Buzaim Lima2, Hidelberto Matos-Silva3, Denis Masashi Sugita4, Mariana Clare Vinaud1, Ruy de Souza Lino-Júnior1.   

Abstract

Neurocysticercosis (NCC) is classified as a neglected tropical disease, which affects mainly Latin America and Africa in spite of some reports in North America and Europe. NCC represents the cause of up to 30% of the reported cases of epilepsy in endemic countries. The NCC injuries present direct relation to the development stage, location, and number of parasites as well as to the host immune response. This study aimed the characterization of the inflammatory response and tissue injuries by means of the analyses of the periventricular and parenchymatous demyelination through the experimental intraventricular NCC infection. Therefore, BALB/c mice were submitted to experimental NCC inoculation with Taenia crassiceps cysticerci. Their brains were removed at 7, 30, 60, and 90 days after the inoculation (DAI), and analyzed after staining with hematoxylin and eosin (HE), Luxol Fast Blue, and Nissl. It was possible to observe ventriculomegaly, inflammatory infiltration composed by polymorphonuclear and mononuclear cells, and foamy macrophages. The presence of inflammatory cells was associated with neurodegeneration detected by the areas with demyelination observed initially in the periventricular area and lately in the parenchyma. In conclusion, the presence of cysticerci and the consequent inflammation were able to promote initial periventricular demyelination followed by parenchymatous demyelination as the infection progressed.

Entities:  

Mesh:

Year:  2020        PMID: 32022135     DOI: 10.1590/0004-282X20190155

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  1 in total

1.  Chronic administration of cryptolepine nanoparticle formulation alleviates seizures in a neurocysticercosis model.

Authors:  Priscilla Kolibea Mante; Nana Ofori Adomako; Paulina Antwi; Nana Kofi Kusi-Boadum
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.